World
USP Launches New Solutions to Strengthen Quality Assurance for GLP-1 Receptor Agonists
The U.S. Pharmacopeia (USP) has launched a new set of solutions to support product quality for manufacturers of glucagon-like peptide-1 (GLP-1) r...
October 24, 2025 | News
Cambrex Announces $120 Million U.S. Expansion to Strengthen API Manufacturing and Peptide Therapeutics Capabilities
Cambrex, a leading global contract development and manufacturing organization (CDMO), announced a $120 million investment to expand i...
October 23, 2025 | News
Thermo Fisher’s PPD Business Launches Carbon Calculator to Drive Sustainable Clinical Research
New tool helps sponsors measure, manage and minimize the environmental impact of research The PPD™ clinical research business of Thermo Fisher Scien...
October 22, 2025 | News
Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions ...
October 21, 2025 | News
ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
Dedicated facilities for gelatin and HPMC; 200+ jobs; operations targeted for early 2027; expands ACG's 25-year U.S. presence ACG, the world's most integr...
October 21, 2025 | News
10x Genomics and Anthropic Partner to Bring Conversational AI to Single Cell and Spatial Biology
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making adva...
October 21, 2025 | News
Aurion Biotech Data Supports Advancing High-Dose AURN001 Regenerative Cell Therapy to Phase 3 Trial in 2026
Data strongly supports advancing high dose AURN001 regenerative cell therapy for patients with corneal endothelial disease to pivotal Phase 3 trial in H1...
October 20, 2025 | News
Merck Presents Longer-Term Phase 3 Data Showing Pimicotinib Achieves 76.2% Objective Response Rate in TGCT
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2% Global Phase 3 MANEUVER study de...
October 20, 2025 | News
Thermo Fisher Partners with OpenAI to Accelerate Drug Development through Artificial Intelligence
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s pro...
October 17, 2025 | News
Merck to Acquire JSR’s Chromatography Business to Strengthen Downstream Bioprocessing Portfolio
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphe...
October 16, 2025 | News
AstraZeneca Invests $445 Million to Expand Texas Manufacturing Hub in the United States, Doubling Global Lokelma Production
AstraZeneca announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the...
October 16, 2025 | News
LTS Acquires Renaissance Lakewood to Expand Global CDMO Capabilities in Nasal and Sterile Drug Delivery
LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company announces the acquisition of Renaissance Lakewood, LLC ("Renaissance")...
October 14, 2025 | News
Waters Launches Xevo™ CDMS to Redefine Mega-Mass Biomolecule Analysis
Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules. Enables accurate analysis of protein comp...
October 14, 2025 | News
IHH Healthcare Launches Global Incubator Programme to Empower Early-Stage Startups
By enabling early-stage start-ups to bring breakthrough ideas to life, IHH is catalysing next-level care and driving lasting impact across the healthc...
October 13, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
